Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of skeletal muscle contraction (GO:0014819) | 9.57376308 |
2 | sarcomere organization (GO:0045214) | 9.22577902 |
3 | actin-myosin filament sliding (GO:0033275) | 8.89895681 |
4 | muscle filament sliding (GO:0030049) | 8.89895681 |
5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 8.78826491 |
6 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 7.88093517 |
7 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.86186396 |
8 | actin-mediated cell contraction (GO:0070252) | 7.40914744 |
9 | myofibril assembly (GO:0030239) | 7.31957678 |
10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.25685398 |
11 | cardiac myofibril assembly (GO:0055003) | 7.19188724 |
12 | plasma membrane repair (GO:0001778) | 7.03302262 |
13 | regulation of relaxation of muscle (GO:1901077) | 6.58093407 |
14 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.57490539 |
15 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 6.44479241 |
16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.41363530 |
17 | cardiac muscle contraction (GO:0060048) | 6.21123906 |
18 | carnitine shuttle (GO:0006853) | 5.95943831 |
19 | cardiac muscle cell development (GO:0055013) | 5.87925228 |
20 | actomyosin structure organization (GO:0031032) | 5.86122267 |
21 | striated muscle contraction (GO:0006941) | 5.84173511 |
22 | regulation of cell communication by electrical coupling (GO:0010649) | 5.83885037 |
23 | skeletal muscle contraction (GO:0003009) | 5.65919120 |
24 | actin filament-based movement (GO:0030048) | 5.64987416 |
25 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.58450062 |
26 | skeletal muscle fiber development (GO:0048741) | 5.57616307 |
27 | cardiac muscle hypertrophy (GO:0003300) | 5.55613016 |
28 | cardiac cell development (GO:0055006) | 5.50622191 |
29 | striated muscle hypertrophy (GO:0014897) | 5.39853092 |
30 | regulation of actin filament-based movement (GO:1903115) | 5.39624522 |
31 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.37110418 |
32 | skeletal muscle adaptation (GO:0043501) | 5.24506034 |
33 | fatty acid transmembrane transport (GO:1902001) | 5.15140198 |
34 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.09834216 |
35 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.07312305 |
36 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.04036695 |
37 | tricarboxylic acid cycle (GO:0006099) | 4.94439036 |
38 | regulation of striated muscle contraction (GO:0006942) | 4.92271240 |
39 | NADH metabolic process (GO:0006734) | 4.88840470 |
40 | muscle hypertrophy (GO:0014896) | 4.77236251 |
41 | creatine metabolic process (GO:0006600) | 4.74323419 |
42 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.74032688 |
43 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.66643143 |
44 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.60033449 |
45 | skeletal muscle tissue development (GO:0007519) | 4.57073195 |
46 | cell communication involved in cardiac conduction (GO:0086065) | 4.49841905 |
47 | adult heart development (GO:0007512) | 4.44878142 |
48 | * cardiac muscle tissue morphogenesis (GO:0055008) | 4.44128327 |
49 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.42210527 |
50 | carnitine transmembrane transport (GO:1902603) | 4.40877701 |
51 | muscle contraction (GO:0006936) | 4.34089668 |
52 | cell communication by electrical coupling (GO:0010644) | 4.31117606 |
53 | response to inactivity (GO:0014854) | 4.27192308 |
54 | regulation of cofactor metabolic process (GO:0051193) | 4.15529078 |
55 | regulation of coenzyme metabolic process (GO:0051196) | 4.15529078 |
56 | * muscle tissue morphogenesis (GO:0060415) | 4.12685398 |
57 | regulation of sarcomere organization (GO:0060297) | 4.11824181 |
58 | cardiac muscle cell action potential (GO:0086001) | 4.09766187 |
59 | striated muscle cell development (GO:0055002) | 4.08879686 |
60 | muscle fiber development (GO:0048747) | 4.05335022 |
61 | regulation of membrane repolarization (GO:0060306) | 4.04928282 |
62 | amino-acid betaine transport (GO:0015838) | 4.01874445 |
63 | carnitine transport (GO:0015879) | 4.01874445 |
64 | muscle system process (GO:0003012) | 3.96888354 |
65 | heart contraction (GO:0060047) | 3.91125533 |
66 | heart process (GO:0003015) | 3.91125533 |
67 | response to muscle activity (GO:0014850) | 3.87858699 |
68 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.87621283 |
69 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.87621283 |
70 | striated muscle atrophy (GO:0014891) | 3.85081113 |
71 | glycogen catabolic process (GO:0005980) | 3.82719324 |
72 | regulation of cardiac muscle contraction (GO:0055117) | 3.82559787 |
73 | striated muscle adaptation (GO:0014888) | 3.82410203 |
74 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.76991302 |
75 | positive regulation of cation channel activity (GO:2001259) | 3.76869950 |
76 | muscle adaptation (GO:0043500) | 3.75066219 |
77 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.72798852 |
78 | muscle structure development (GO:0061061) | 3.70865104 |
79 | muscle organ development (GO:0007517) | 3.68393749 |
80 | glycogen metabolic process (GO:0005977) | 3.67715271 |
81 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.65978938 |
82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.65929563 |
83 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.65929563 |
84 | detection of calcium ion (GO:0005513) | 3.61305096 |
85 | muscle cell fate commitment (GO:0042693) | 3.61003404 |
86 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.60689418 |
87 | glucan metabolic process (GO:0044042) | 3.60434793 |
88 | cellular glucan metabolic process (GO:0006073) | 3.60434793 |
89 | muscle hypertrophy in response to stress (GO:0003299) | 3.58613541 |
90 | cardiac muscle adaptation (GO:0014887) | 3.58613541 |
91 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.58613541 |
92 | glucan catabolic process (GO:0009251) | 3.56717443 |
93 | muscle cell cellular homeostasis (GO:0046716) | 3.51865659 |
94 | muscle cell development (GO:0055001) | 3.47623302 |
95 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.47014899 |
96 | skeletal muscle tissue regeneration (GO:0043403) | 3.42896121 |
97 | regulation of sulfur metabolic process (GO:0042762) | 3.42811802 |
98 | relaxation of muscle (GO:0090075) | 3.39961524 |
99 | positive regulation of myotube differentiation (GO:0010831) | 3.39204674 |
100 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.38110290 |
101 | regulation of heart rate (GO:0002027) | 3.37709107 |
102 | response to activity (GO:0014823) | 3.35576589 |
103 | cellular polysaccharide catabolic process (GO:0044247) | 3.34309965 |
104 | myotube differentiation (GO:0014902) | 3.32750744 |
105 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.32437150 |
106 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.32406471 |
107 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.31470619 |
108 | regulation of myoblast differentiation (GO:0045661) | 3.30941086 |
109 | glucan biosynthetic process (GO:0009250) | 3.29927736 |
110 | glycogen biosynthetic process (GO:0005978) | 3.29927736 |
111 | regulation of muscle contraction (GO:0006937) | 3.29700530 |
112 | muscle atrophy (GO:0014889) | 3.28816336 |
113 | myotube cell development (GO:0014904) | 3.28578838 |
114 | heart trabecula formation (GO:0060347) | 3.27829456 |
115 | 2-oxoglutarate metabolic process (GO:0006103) | 3.27482088 |
116 | response to caffeine (GO:0031000) | 3.25047556 |
117 | striated muscle tissue development (GO:0014706) | 3.24910190 |
118 | regulation of the force of heart contraction (GO:0002026) | 3.23983848 |
119 | gluconeogenesis (GO:0006094) | 3.23136432 |
120 | relaxation of cardiac muscle (GO:0055119) | 3.22558968 |
121 | regulation of ATPase activity (GO:0043462) | 3.22131861 |
122 | regulation of ATP catabolic process (GO:1903289) | 3.22131861 |
123 | regulation of muscle system process (GO:0090257) | 3.19431221 |
124 | polysaccharide catabolic process (GO:0000272) | 3.17522211 |
125 | cytidine deamination (GO:0009972) | 3.16450238 |
126 | cytidine catabolic process (GO:0006216) | 3.16450238 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82908110 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.36208130 |
3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.21803135 |
4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.71916879 |
5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.71916879 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.12474985 |
7 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.09908670 |
8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.03419839 |
9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.97164396 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.96293059 |
11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.56936472 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52456333 |
13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.43052908 |
14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.38100875 |
15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31204927 |
16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.25256683 |
17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20017939 |
18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11464774 |
19 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.99827683 |
20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87988029 |
21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65769808 |
22 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.65351887 |
23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64338523 |
24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.64091577 |
25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62273103 |
26 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.54630406 |
27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.53531530 |
28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50680322 |
29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44689931 |
30 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.41016410 |
31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39506594 |
32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37332655 |
33 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.30538972 |
34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29648472 |
35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28872708 |
36 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.27335415 |
37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25994538 |
38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.24417444 |
39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23125829 |
40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20872957 |
41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19331001 |
42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19290149 |
43 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18269372 |
44 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17931435 |
45 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17551284 |
46 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16149372 |
47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15801396 |
48 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14991232 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14175363 |
50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13784689 |
51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12816116 |
52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11751882 |
53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11343659 |
54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11269637 |
55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10491367 |
56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09556452 |
57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08389736 |
58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07739902 |
59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07651985 |
60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07638545 |
61 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07118795 |
62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06572015 |
63 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04955926 |
64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04309377 |
65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03500086 |
66 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02184124 |
67 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02168900 |
68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01975839 |
69 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01726184 |
70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01615949 |
71 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00389952 |
72 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97382607 |
73 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.96504231 |
74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94933764 |
75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92899201 |
76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92773044 |
77 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92666431 |
78 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92347324 |
79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91178453 |
80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91012300 |
81 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.90950763 |
82 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.89998125 |
83 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89929908 |
84 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.89446099 |
85 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89381761 |
86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88946181 |
87 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88367877 |
88 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87981657 |
89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87857295 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87144218 |
91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86344268 |
92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86255487 |
93 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85786295 |
94 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.85736211 |
95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85511178 |
96 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.84503257 |
97 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83956081 |
98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83901816 |
99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83901816 |
100 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83674215 |
101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83191646 |
102 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82679998 |
103 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82650680 |
104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82115147 |
105 | TBL1_22424771_ChIP-Seq_293T_Human | 0.81958145 |
106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81192073 |
107 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.80859975 |
108 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80828686 |
109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80496190 |
110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80091591 |
111 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79074881 |
112 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78862985 |
113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.78307103 |
114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78276169 |
115 | CBP_21632823_ChIP-Seq_H3396_Human | 0.77103159 |
116 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.77017462 |
117 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.76960224 |
118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76407417 |
119 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.76127830 |
120 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.76106242 |
121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76024754 |
122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.75870876 |
123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75579694 |
124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75573041 |
125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75043939 |
126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75005775 |
127 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.74965683 |
128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74750941 |
129 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73949361 |
130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.73739618 |
131 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.73739618 |
132 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.73549161 |
133 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.73330678 |
134 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.73273839 |
135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73118515 |
136 | NFYB_21822215_ChIP-Seq_K562_Human | 0.69624462 |
137 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.69541672 |
138 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.68651664 |
139 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.68323127 |
140 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.68198931 |
141 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.68192783 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000751_myopathy | 6.15494271 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 5.88861658 |
3 | MP0003646_muscle_fatigue | 5.59529342 |
4 | MP0000749_muscle_degeneration | 5.16543603 |
5 | MP0004145_abnormal_muscle_electrophysio | 4.66496161 |
6 | MP0004215_abnormal_myocardial_fiber | 4.26475681 |
7 | MP0004084_abnormal_cardiac_muscle | 4.23915055 |
8 | MP0004036_abnormal_muscle_relaxation | 3.90775024 |
9 | MP0005330_cardiomyopathy | 3.50535545 |
10 | * MP0004087_abnormal_muscle_fiber | 3.34757659 |
11 | MP0000750_abnormal_muscle_regeneration | 3.34737048 |
12 | MP0002106_abnormal_muscle_physiology | 3.31341181 |
13 | MP0000747_muscle_weakness | 3.11641308 |
14 | MP0002269_muscular_atrophy | 3.02345399 |
15 | MP0004130_abnormal_muscle_cell | 2.95887656 |
16 | MP0005620_abnormal_muscle_contractility | 2.94700624 |
17 | MP0004510_myositis | 2.88148158 |
18 | MP0005369_muscle_phenotype | 2.69420213 |
19 | MP0000759_abnormal_skeletal_muscle | 2.68120009 |
20 | MP0002972_abnormal_cardiac_muscle | 2.58946763 |
21 | MP0003137_abnormal_impulse_conducting | 2.45202582 |
22 | MP0008775_abnormal_heart_ventricle | 2.38577831 |
23 | MP0004484_altered_response_of | 2.37970197 |
24 | * MP0010630_abnormal_cardiac_muscle | 2.25673909 |
25 | MP0003950_abnormal_plasma_membrane | 2.01096735 |
26 | * MP0005385_cardiovascular_system_phenoty | 1.97366809 |
27 | * MP0001544_abnormal_cardiovascular_syste | 1.97366809 |
28 | MP0004233_abnormal_muscle_weight | 1.91196942 |
29 | MP0002127_abnormal_cardiovascular_syste | 1.75958410 |
30 | MP0002332_abnormal_exercise_endurance | 1.58393982 |
31 | MP0006036_abnormal_mitochondrial_physio | 1.58070932 |
32 | MP0004085_abnormal_heartbeat | 1.55160976 |
33 | MP0006138_congestive_heart_failure | 1.48634820 |
34 | MP0005666_abnormal_adipose_tissue | 1.44608362 |
35 | MP0003828_pulmonary_edema | 1.43524576 |
36 | MP0005670_abnormal_white_adipose | 1.41259751 |
37 | MP0002108_abnormal_muscle_morphology | 1.37724165 |
38 | MP0000733_abnormal_muscle_development | 1.33345443 |
39 | * MP0003221_abnormal_cardiomyocyte_apopto | 1.30915923 |
40 | MP0003045_fibrosis | 1.26056914 |
41 | MP0004185_abnormal_adipocyte_glucose | 1.15618568 |
42 | MP0000343_altered_response_to | 1.03670645 |
43 | MP0005375_adipose_tissue_phenotype | 0.97810334 |
44 | MP0006035_abnormal_mitochondrial_morpho | 0.97782870 |
45 | * MP0000266_abnormal_heart_morphology | 0.94146171 |
46 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93849587 |
47 | MP0005165_increased_susceptibility_to | 0.82510537 |
48 | MP0002971_abnormal_brown_adipose | 0.79954280 |
49 | MP0005266_abnormal_metabolism | 0.76350762 |
50 | MP0010368_abnormal_lymphatic_system | 0.75385487 |
51 | MP0000372_irregular_coat_pigmentation | 0.71470819 |
52 | MP0002234_abnormal_pharynx_morphology | 0.69445514 |
53 | MP0000013_abnormal_adipose_tissue | 0.68574756 |
54 | MP0002822_catalepsy | 0.68050284 |
55 | MP0003705_abnormal_hypodermis_morpholog | 0.66466054 |
56 | MP0005275_abnormal_skin_tensile | 0.65890102 |
57 | * MP0002128_abnormal_blood_circulation | 0.61462486 |
58 | MP0003806_abnormal_nucleotide_metabolis | 0.58530126 |
59 | MP0003879_abnormal_hair_cell | 0.54088128 |
60 | MP0005623_abnormal_meninges_morphology | 0.53923198 |
61 | MP0003566_abnormal_cell_adhesion | 0.53599163 |
62 | MP0000230_abnormal_systemic_arterial | 0.53534285 |
63 | MP0003279_aneurysm | 0.52973211 |
64 | MP0004134_abnormal_chest_morphology | 0.50295337 |
65 | MP0000003_abnormal_adipose_tissue | 0.50287121 |
66 | MP0004043_abnormal_pH_regulation | 0.49762869 |
67 | MP0004147_increased_porphyrin_level | 0.48798601 |
68 | MP0002078_abnormal_glucose_homeostasis | 0.47178737 |
69 | MP0008961_abnormal_basal_metabolism | 0.46822353 |
70 | MP0001299_abnormal_eye_distance/ | 0.46466812 |
71 | MP0005334_abnormal_fat_pad | 0.44184452 |
72 | MP0001879_abnormal_lymphatic_vessel | 0.43846372 |
73 | MP0005319_abnormal_enzyme/_coenzyme | 0.42528667 |
74 | MP0005167_abnormal_blood-brain_barrier | 0.42512975 |
75 | MP0002909_abnormal_adrenal_gland | 0.42483514 |
76 | MP0009780_abnormal_chondrocyte_physiolo | 0.42376917 |
77 | MP0001661_extended_life_span | 0.41357275 |
78 | MP0002638_abnormal_pupillary_reflex | 0.40596941 |
79 | MP0008438_abnormal_cutaneous_collagen | 0.39703432 |
80 | MP0004142_abnormal_muscle_tone | 0.38442829 |
81 | MP0000767_abnormal_smooth_muscle | 0.38426472 |
82 | MP0002168_other_aberrant_phenotype | 0.36391971 |
83 | MP0005376_homeostasis/metabolism_phenot | 0.33494044 |
84 | MP0005187_abnormal_penis_morphology | 0.32697042 |
85 | MP0002925_abnormal_cardiovascular_devel | 0.32588470 |
86 | MP0003948_abnormal_gas_homeostasis | 0.30310436 |
87 | MP0005535_abnormal_body_temperature | 0.29770721 |
88 | MP0002114_abnormal_axial_skeleton | 0.28442954 |
89 | MP0000579_abnormal_nail_morphology | 0.28290187 |
90 | MP0005423_abnormal_somatic_nervous | 0.27748320 |
91 | MP0005166_decreased_susceptibility_to | 0.27686541 |
92 | MP0009115_abnormal_fat_cell | 0.27489437 |
93 | MP0002734_abnormal_mechanical_nocicepti | 0.26558289 |
94 | MP0000762_abnormal_tongue_morphology | 0.26371946 |
95 | MP0001784_abnormal_fluid_regulation | 0.26084102 |
96 | MP0002896_abnormal_bone_mineralization | 0.25320798 |
97 | MP0003656_abnormal_erythrocyte_physiolo | 0.25214301 |
98 | MP0001614_abnormal_blood_vessel | 0.24685092 |
99 | MP0005452_abnormal_adipose_tissue | 0.23411127 |
100 | MP0005451_abnormal_body_composition | 0.23022017 |
101 | MP0001984_abnormal_olfaction | 0.22659031 |
102 | MP0002118_abnormal_lipid_homeostasis | 0.22019228 |
103 | MP0004270_analgesia | 0.21081604 |
104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.20733295 |
105 | MP0009250_abnormal_appendicular_skeleto | 0.20596080 |
106 | MP0006276_abnormal_autonomic_nervous | 0.20135834 |
107 | MP0001943_abnormal_respiration | 0.19704969 |
108 | MP0005332_abnormal_amino_acid | 0.19255166 |
109 | MP0010030_abnormal_orbit_morphology | 0.18388808 |
110 | MP0005386_behavior/neurological_phenoty | 0.16908246 |
111 | MP0004924_abnormal_behavior | 0.16908246 |
112 | MP0008569_lethality_at_weaning | 0.16608001 |
113 | MP0001853_heart_inflammation | 0.16252319 |
114 | MP0004272_abnormal_basement_membrane | 0.16144275 |
115 | * MP0002066_abnormal_motor_capabilities/c | 0.15971271 |
116 | MP0003984_embryonic_growth_retardation | 0.15603200 |
117 | MP0002876_abnormal_thyroid_physiology | 0.14697473 |
118 | MP0002088_abnormal_embryonic_growth/wei | 0.14519864 |
119 | MP0008874_decreased_physiological_sensi | 0.14361168 |
120 | MP0003195_calcinosis | 0.14233834 |
121 | MP0003941_abnormal_skin_development | 0.12464212 |
122 | MP0005083_abnormal_biliary_tract | 0.12419139 |
123 | MP0004197_abnormal_fetal_growth/weight/ | 0.10951383 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 7.29139014 |
2 | Exercise-induced myalgia (HP:0003738) | 7.02631890 |
3 | Calf muscle hypertrophy (HP:0008981) | 7.00573143 |
4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.94971875 |
5 | Muscle fiber splitting (HP:0003555) | 6.85947090 |
6 | Exercise-induced muscle cramps (HP:0003710) | 6.58702645 |
7 | Muscle fiber inclusion bodies (HP:0100299) | 6.51143381 |
8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.36095652 |
9 | Hyporeflexia of lower limbs (HP:0002600) | 5.76723099 |
10 | Abnormality of the calf musculature (HP:0001430) | 5.74042308 |
11 | Nemaline bodies (HP:0003798) | 5.46947830 |
12 | Ventricular tachycardia (HP:0004756) | 5.44748176 |
13 | Type 1 muscle fiber predominance (HP:0003803) | 5.03375763 |
14 | Myoglobinuria (HP:0002913) | 5.01476444 |
15 | EMG: myopathic abnormalities (HP:0003458) | 4.95495159 |
16 | Difficulty running (HP:0009046) | 4.91285158 |
17 | Increased connective tissue (HP:0009025) | 4.83442042 |
18 | Right ventricular cardiomyopathy (HP:0011663) | 4.72984093 |
19 | Atrial fibrillation (HP:0005110) | 4.61103512 |
20 | Primary atrial arrhythmia (HP:0001692) | 4.30049069 |
21 | Lipoatrophy (HP:0100578) | 4.27652424 |
22 | Supraventricular tachycardia (HP:0004755) | 4.14411452 |
23 | Distal arthrogryposis (HP:0005684) | 4.05391838 |
24 | Supraventricular arrhythmia (HP:0005115) | 4.04952142 |
25 | Syncope (HP:0001279) | 4.03970925 |
26 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.96747194 |
27 | Subaortic stenosis (HP:0001682) | 3.96747194 |
28 | Rhabdomyolysis (HP:0003201) | 3.91394103 |
29 | Myotonia (HP:0002486) | 3.88992899 |
30 | Round ear (HP:0100830) | 3.84486439 |
31 | Myopathic facies (HP:0002058) | 3.81197232 |
32 | Difficulty climbing stairs (HP:0003551) | 3.77607499 |
33 | Dilated cardiomyopathy (HP:0001644) | 3.67585700 |
34 | Bundle branch block (HP:0011710) | 3.65553810 |
35 | Rimmed vacuoles (HP:0003805) | 3.41007275 |
36 | Muscle stiffness (HP:0003552) | 3.37031446 |
37 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.32025273 |
38 | Prolonged QT interval (HP:0001657) | 3.31584996 |
39 | Ventricular arrhythmia (HP:0004308) | 3.30559947 |
40 | Ulnar deviation of the wrist (HP:0003049) | 3.29759990 |
41 | Increased variability in muscle fiber diameter (HP:0003557) | 3.29045970 |
42 | Asymmetric septal hypertrophy (HP:0001670) | 3.26833796 |
43 | Neck muscle weakness (HP:0000467) | 3.26358364 |
44 | Areflexia of lower limbs (HP:0002522) | 3.24416128 |
45 | Palpitations (HP:0001962) | 3.14370786 |
46 | Heart block (HP:0012722) | 3.04092931 |
47 | Abnormal atrioventricular conduction (HP:0005150) | 2.88751898 |
48 | Muscular dystrophy (HP:0003560) | 2.84673174 |
49 | Atrioventricular block (HP:0001678) | 2.72805386 |
50 | Hypoplastic ischia (HP:0003175) | 2.72147137 |
51 | Distal lower limb muscle weakness (HP:0009053) | 2.71056404 |
52 | Fetal akinesia sequence (HP:0001989) | 2.70646070 |
53 | Calcaneovalgus deformity (HP:0001848) | 2.68602028 |
54 | Facial diplegia (HP:0001349) | 2.59315568 |
55 | Slender build (HP:0001533) | 2.55942758 |
56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.51654023 |
57 | Absent phalangeal crease (HP:0006109) | 2.48965499 |
58 | Distal lower limb amyotrophy (HP:0008944) | 2.48810246 |
59 | Gowers sign (HP:0003391) | 2.43665638 |
60 | Deformed tarsal bones (HP:0008119) | 2.42593732 |
61 | Frequent falls (HP:0002359) | 2.38677306 |
62 | Abnormality of the ischium (HP:0003174) | 2.37552791 |
63 | Abnormal EKG (HP:0003115) | 2.36949936 |
64 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.35022450 |
65 | Ventricular fibrillation (HP:0001663) | 2.34965326 |
66 | EMG: neuropathic changes (HP:0003445) | 2.31981726 |
67 | Weak cry (HP:0001612) | 2.25949644 |
68 | Proximal amyotrophy (HP:0007126) | 2.23306594 |
69 | Testicular atrophy (HP:0000029) | 2.23184342 |
70 | Generalized muscle weakness (HP:0003324) | 2.23053426 |
71 | Scapular winging (HP:0003691) | 2.22006923 |
72 | Hip contracture (HP:0003273) | 2.21935646 |
73 | Limb-girdle muscle atrophy (HP:0003797) | 2.21342653 |
74 | Palmoplantar keratoderma (HP:0000982) | 2.12421574 |
75 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.11100418 |
76 | Left ventricular hypertrophy (HP:0001712) | 2.07371547 |
77 | Ketoacidosis (HP:0001993) | 2.06797538 |
78 | Abnormal finger flexion creases (HP:0006143) | 2.01873246 |
79 | Abnormality of the calcaneus (HP:0008364) | 2.01231797 |
80 | Fatigable weakness (HP:0003473) | 1.98505646 |
81 | Abnormality of the neuromuscular junction (HP:0003398) | 1.98505646 |
82 | Foot dorsiflexor weakness (HP:0009027) | 1.98314029 |
83 | Progressive muscle weakness (HP:0003323) | 1.95380229 |
84 | Abnormality of the foot musculature (HP:0001436) | 1.93929652 |
85 | Lower limb amyotrophy (HP:0007210) | 1.92042895 |
86 | Ragged-red muscle fibers (HP:0003200) | 1.88618218 |
87 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.88615633 |
88 | Hypoglycemic coma (HP:0001325) | 1.88395158 |
89 | Limited hip movement (HP:0008800) | 1.84707628 |
90 | Long clavicles (HP:0000890) | 1.83236486 |
91 | Toxemia of pregnancy (HP:0100603) | 1.83191606 |
92 | Hyperkalemia (HP:0002153) | 1.82912877 |
93 | Malignant hyperthermia (HP:0002047) | 1.82565723 |
94 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.81901852 |
95 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.81240492 |
96 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.81240492 |
97 | Sudden cardiac death (HP:0001645) | 1.78032654 |
98 | Bulbar palsy (HP:0001283) | 1.77559592 |
99 | Limb-girdle muscle weakness (HP:0003325) | 1.76333876 |
100 | Pelvic girdle muscle weakness (HP:0003749) | 1.75211310 |
101 | Shoulder girdle muscle weakness (HP:0003547) | 1.74904730 |
102 | Hyperglycemia (HP:0003074) | 1.74597159 |
103 | Waddling gait (HP:0002515) | 1.74003737 |
104 | Spinal rigidity (HP:0003306) | 1.72989530 |
105 | Oligomenorrhea (HP:0000876) | 1.71150378 |
106 | Diaphragmatic weakness (HP:0009113) | 1.70949069 |
107 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.68476103 |
108 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.67681094 |
109 | Hepatic necrosis (HP:0002605) | 1.67129489 |
110 | Exercise intolerance (HP:0003546) | 1.66088494 |
111 | Nonprogressive disorder (HP:0003680) | 1.66006423 |
112 | Steppage gait (HP:0003376) | 1.65792296 |
113 | Cholelithiasis (HP:0001081) | 1.61981807 |
114 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.61892117 |
115 | Hypoalphalipoproteinemia (HP:0003233) | 1.61798010 |
116 | Type 2 muscle fiber atrophy (HP:0003554) | 1.61315858 |
117 | Popliteal pterygium (HP:0009756) | 1.58891057 |
118 | Paralysis (HP:0003470) | 1.53818971 |
119 | Muscle fiber atrophy (HP:0100295) | 1.45321357 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 8.99299069 |
2 | TTN | 5.62152549 |
3 | PHKG1 | 4.42602011 |
4 | PHKG2 | 4.42602011 |
5 | DMPK | 2.99536295 |
6 | MUSK | 2.91048762 |
7 | PDK4 | 2.64378989 |
8 | PDK3 | 2.64378989 |
9 | ZAK | 2.55768485 |
10 | PIK3CG | 2.26252135 |
11 | LMTK2 | 1.98333431 |
12 | NME1 | 1.96148746 |
13 | PINK1 | 1.93530100 |
14 | TRIB3 | 1.90970407 |
15 | PIK3CA | 1.86751387 |
16 | INSRR | 1.81533560 |
17 | NEK1 | 1.80377809 |
18 | PKN2 | 1.68713851 |
19 | PDK2 | 1.62146179 |
20 | BCKDK | 1.59947433 |
21 | MAP3K7 | 1.55124621 |
22 | MYLK | 1.47623175 |
23 | MAP2K3 | 1.45472316 |
24 | MARK1 | 1.23608950 |
25 | TIE1 | 1.17422426 |
26 | MAPK12 | 1.16130632 |
27 | CAMK2D | 1.11532840 |
28 | LIMK1 | 1.07709923 |
29 | GRK7 | 1.05425233 |
30 | CCNB1 | 1.00536889 |
31 | EEF2K | 0.96257954 |
32 | PRKD1 | 0.96224519 |
33 | PRKAA2 | 0.93836835 |
34 | MAP3K3 | 0.91643676 |
35 | STK24 | 0.90717279 |
36 | PRKAA1 | 0.89591536 |
37 | ILK | 0.86314888 |
38 | EPHB1 | 0.85763508 |
39 | PKN1 | 0.83356004 |
40 | SIK1 | 0.82571030 |
41 | TRPM7 | 0.76654053 |
42 | MOS | 0.76099055 |
43 | ERBB3 | 0.75654667 |
44 | RIPK1 | 0.74392892 |
45 | MAPKAPK3 | 0.66569093 |
46 | ROCK1 | 0.65469900 |
47 | MAP2K4 | 0.64919516 |
48 | PAK3 | 0.63137242 |
49 | AKT2 | 0.62665485 |
50 | NEK9 | 0.59756956 |
51 | MAP3K5 | 0.58671785 |
52 | MAP3K13 | 0.50996698 |
53 | LATS1 | 0.48629956 |
54 | CAMK2B | 0.46969504 |
55 | CAMK4 | 0.46723978 |
56 | WNK1 | 0.46065885 |
57 | MAP2K6 | 0.45765179 |
58 | STK38L | 0.45736730 |
59 | DYRK1B | 0.45365525 |
60 | MAP2K1 | 0.43103315 |
61 | PDGFRA | 0.42815492 |
62 | CAMK2A | 0.40917552 |
63 | STK38 | 0.40568778 |
64 | PRKACB | 0.40550124 |
65 | CAMK2G | 0.39359580 |
66 | SGK2 | 0.38964200 |
67 | KSR2 | 0.37201979 |
68 | FLT3 | 0.36290617 |
69 | PRKACA | 0.35861665 |
70 | CAMK1G | 0.35769315 |
71 | WNK4 | 0.33521267 |
72 | PRKG1 | 0.33092735 |
73 | CDC42BPA | 0.33031053 |
74 | ROCK2 | 0.32111120 |
75 | PRKACG | 0.30754730 |
76 | CAMK1 | 0.30393479 |
77 | PTK6 | 0.29294829 |
78 | STK4 | 0.29062151 |
79 | TBK1 | 0.28636497 |
80 | TGFBR2 | 0.27705587 |
81 | PTK2B | 0.26959402 |
82 | MAPK11 | 0.26415081 |
83 | MARK2 | 0.25926690 |
84 | SGK1 | 0.24391230 |
85 | RPS6KB1 | 0.23981807 |
86 | JAK1 | 0.23223183 |
87 | RPS6KA3 | 0.22049360 |
88 | MAPK10 | 0.21796848 |
89 | LATS2 | 0.21433583 |
90 | MTOR | 0.21228970 |
91 | NLK | 0.21225913 |
92 | PDPK1 | 0.20633685 |
93 | TAOK1 | 0.20188976 |
94 | ICK | 0.19884438 |
95 | SGK3 | 0.19581906 |
96 | PDGFRB | 0.19283104 |
97 | CAMK1D | 0.18624880 |
98 | MAP3K10 | 0.18375645 |
99 | ZAP70 | 0.17486809 |
100 | PDK1 | 0.16967443 |
101 | MAPK13 | 0.16889910 |
102 | SGK223 | 0.16803225 |
103 | SGK494 | 0.16803225 |
104 | MARK3 | 0.16719077 |
105 | RPS6KA1 | 0.16510797 |
106 | RPS6KB2 | 0.15952438 |
107 | PRKCE | 0.15673767 |
108 | RPS6KL1 | 0.15565031 |
109 | RPS6KC1 | 0.15565031 |
110 | PRKCH | 0.14853360 |
111 | MAPK7 | 0.14802987 |
112 | FGFR4 | 0.14097924 |
113 | FER | 0.13766428 |
114 | RET | 0.13651816 |
115 | TAOK2 | 0.12550499 |
116 | KDR | 0.12428513 |
117 | MAP3K1 | 0.11112904 |
118 | EPHA3 | 0.11007863 |
119 | FGFR3 | 0.10376085 |
120 | DAPK3 | 0.10154644 |
121 | MAP3K6 | 0.10037987 |
122 | MAPK4 | 0.09360310 |
123 | STK11 | 0.09345388 |
124 | DAPK2 | 0.09098868 |
125 | RPS6KA6 | 0.09012959 |
126 | PAK6 | 0.07856764 |
127 | PRPF4B | 0.07626524 |
128 | PRKG2 | 0.07573595 |
129 | RAF1 | 0.06172259 |
130 | MAPK9 | 0.04009948 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.94965044 |
2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.50245338 |
3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.28163530 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.05084498 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.61622524 |
6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.59094582 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95878817 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.90142434 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40764847 |
10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.15309503 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.14760237 |
12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.02386683 |
13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.99390148 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90656039 |
15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.89511682 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81652761 |
17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.79396417 |
18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.70908882 |
19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.62094117 |
20 | Insulin resistance_Homo sapiens_hsa04931 | 1.60987650 |
21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56047868 |
22 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.49154031 |
23 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.44120849 |
24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.38885195 |
25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36141363 |
26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.30774944 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23779577 |
28 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21682718 |
29 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17820462 |
30 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.12474979 |
31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10654747 |
32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06031216 |
33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05647764 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05558449 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.02690190 |
36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00792821 |
37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99436175 |
38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98708489 |
39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90756817 |
40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90747984 |
41 | Focal adhesion_Homo sapiens_hsa04510 | 0.88407867 |
42 | Lysine degradation_Homo sapiens_hsa00310 | 0.85630588 |
43 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85162118 |
44 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82967193 |
45 | Renin secretion_Homo sapiens_hsa04924 | 0.80429311 |
46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78215583 |
47 | Tight junction_Homo sapiens_hsa04530 | 0.76962868 |
48 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75189118 |
49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74382216 |
50 | Insulin secretion_Homo sapiens_hsa04911 | 0.74323285 |
51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72591587 |
52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69116158 |
53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68036636 |
54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67196980 |
55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66196482 |
56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66030113 |
57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62767958 |
58 | Adherens junction_Homo sapiens_hsa04520 | 0.61321593 |
59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60538758 |
60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58748247 |
61 | Circadian entrainment_Homo sapiens_hsa04713 | 0.56011706 |
62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55163118 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54217468 |
64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49992734 |
65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49095516 |
66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48109662 |
67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47856069 |
68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46012959 |
69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44627759 |
70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44155634 |
71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44037766 |
72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42218998 |
73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42100130 |
74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39967491 |
75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37420443 |
76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36988123 |
77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36261336 |
78 | Amoebiasis_Homo sapiens_hsa05146 | 0.35579379 |
79 | Long-term depression_Homo sapiens_hsa04730 | 0.34649087 |
80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34198500 |
81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32491187 |
82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32314302 |
83 | Platelet activation_Homo sapiens_hsa04611 | 0.31569195 |
84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30899095 |
85 | Peroxisome_Homo sapiens_hsa04146 | 0.28103800 |
86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27899694 |
87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27691121 |
88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26818267 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25064917 |
90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23649791 |
91 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.20325028 |
92 | Glioma_Homo sapiens_hsa05214 | 0.18754317 |
93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16921210 |
94 | Purine metabolism_Homo sapiens_hsa00230 | 0.16842037 |
95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15134744 |
96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.14055055 |
97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.13472444 |
98 | Melanogenesis_Homo sapiens_hsa04916 | 0.12593369 |
99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.12301862 |
100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11742169 |
101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.11183136 |
102 | Bile secretion_Homo sapiens_hsa04976 | 0.10536171 |
103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.10143123 |
104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.09722255 |
105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09277978 |
106 | ABC transporters_Homo sapiens_hsa02010 | 0.08763633 |
107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.07318353 |
108 | Taste transduction_Homo sapiens_hsa04742 | 0.07309768 |
109 | Gap junction_Homo sapiens_hsa04540 | 0.07190684 |
110 | Salmonella infection_Homo sapiens_hsa05132 | 0.07042061 |
111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.06393716 |
112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.05269315 |
113 | Salivary secretion_Homo sapiens_hsa04970 | 0.05097587 |